Reported about 10 hours ago
Cellebrite DI Ltd. (NASDAQ:CLBT) has seen its stock surge for three consecutive days, rising 9.29% to $15.29 following a profitable second quarter. The company reported a net income of $19.48 million, a significant turnaround from last year's loss, and an 18% revenue increase to $113.28 million. Despite the positive results, Cellebrite revised its full-year revenue outlook down slightly, prompting an investment firm to lower its price target while still maintaining a 'buy' recommendation.
Source: YAHOO